A modified ultra-long pituitary downregulation protocol improved endometrial receptivity and clinical outcome for infertile patients with polycystic ovarian syndrome

Experimental and Therapeutic Medicine

Volumn 10, Issue 5, 2015, Pages 1865-1870

  Gong, Fei ^a,b,c   Li, Xihong ^b   Zhang, Shunji ^b   Ma, Hainan ^b   Cai, Sufen ^b   Li, Juan ^b   Lin, Ge ^a,b,c   Lu, Guangxiu ^a,b,c  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b Reproductive and Genetic Hospital of Citic Xiangya   (China)

^c BEIJING HOSPITAL   (China)

Author keywords

Endometrial receptivity; Polycystic ovarian syndrome; Ultra long downregulation protocol

Indexed keywords

FOLLITROPIN; GESTAGEN; GONADORELIN AGONIST; GONADOTROPIN;

ADULT; ARTICLE; BLOOD FLOW; CLINICAL ASSESSMENT; CONTROLLED STUDY; DOWN REGULATION; EMBRYO GROWTH; EMBRYO TRANSFER; ENDOMETRIAL RECEPTION; ENDOMETRIAL THICKNESS; FEMALE; FEMALE GENITAL SYSTEM FUNCTION; FERTILIZATION IN VITRO; FOLLICULAR ASPIRATION; HORMONAL REGULATION; HUMAN; INFERTILITY; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; OVARY HYPERSTIMULATION; OVARY POLYCYSTIC DISEASE; PITUITARY HORMONE DOWNREGULATION; PREGNANCY OUTCOME; RETROSPECTIVE STUDY; TRANSVAGINAL ECHOGRAPHY;

EID: 84942238430     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2015.2769     Document Type: Article

References (31)

1. Sheehan MT: Polycystic ovarian syndrome: Diagnosis and management. Clin Med Res 2: 13-27, 2004.
2. Hart R: Polycystic ovarian syndrome-prognosis and treatment outcomes. Curr Opin Obstet Gynecol 19: 529-535, 2007.
3. Chen ZJ and Shi Y: Polycystic ovary syndrome. Front Med China 4: 280-284, 2010.
4. Elnashar AM: Progesterone rise on the day of HCG administration (premature luteinization) in IVF: An overdue update. J Assist Reprod Genet 27: 149-155, 2010.
5. Pundir J, Sunkara SK, El-Toukhy T and Khalaf Y: Meta-analysis of GnRH antagonist protocols: Do they reduce the risk of OHSS in PCOS? Reprod Biomed Online 24: 6-22, 2012.
6. Orvieto R, Meltcer S, Liberty G, Rabinson J, Anteby EY and Nahum R: Does day-3 LH/FSH ratio influence in vitro fertilization outcome in PCOS patients undergoing controlled ovarian hyperstimulation with different GnRH-analogue? Gynecol Endocrinol 28: 422-424, 2012.
7. Rickes D, Nickel I, Kropf S and Kleinstein J: Increased pregnancy rates after ultralong postoperative therapy with gonadotropin-releasing hormone analogs in patients with endometriosis. Fertil Steril 78: 757-762, 2002.
8. Surrey ES, Silverberg KM, Surrey MW and Schoolcraft WB: Effect of prolonged gonadotropin-releasing hormone agonist therapy on the outcome of in vitro fertilization-embryo transfer in patients with endometriosis. Fertil Steril 78: 699-704, 2002.
9. Mijatovic V, Florijn E, Halim N, Schats R and Hompes P: Adenomyosis has no adverse effects on IVF/ICSI outcomes in women with endometriosis treated with long-term pituitary down-regulation before IVF/ICSI. Eur J Obstet Gynecol Reprod Biol 151: 62-65, 2010.
10. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group: Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 19: 41-47, 2004.
11. Alper MM, Brinsden PR, Fischer R and Wikland M: Is your IVF programme good? Hum Reprod 17: 8-10, 2002.
12. Gonen Y and Casper RF: Prediction of implantation by the sonographic appearance of the endometrium during controlled ovarian stimulation for in vitro fertilization (IVF). J In Vitro Fert Embryo Transf 7: 146-152, 1990.
13. Chien LW, Au HK, Chen PL, Xiao J and Tzeng CR: Assessment of uterine receptivity by the endometrial-subendometrial blood flow distribution pattern in women undergoing in vitro fertilization-embryo transfer. Fertil Steril 78: 245-251, 2002.
14. Bosch E, Valencia I, Escudero E, Crespo J, Simón C, Remohí J and Pellicer A: Premature luteinization during gonadotropin-releasing hormone antagonist cycles and its relationship with in vitro fertilization outcome. Fertil Steril 80: 1444-1449, 2003.
15. Elgindy EA: Progesterone level and progesterone/estradiol ratio on the day of hCG administration: Detrimental cutoff levels and new treatment strategy. Fertil Steril 95: 1639-1644, 2011.
16. Wu Z, Li R, Ma Y, Deng B, Zhang X, Meng Y, Chen X, Liu P and Qiao J: Effect of HCG-day serum progesterone and oestradiol concentrations on pregnancy outcomes in GnRH agonist cycles. Reprod Biomed Online 24: 511-520, 2012.
17. Papanikolaou EG, Pados G, Grimbizis G, Bili E, Kyriazi L, Polyzos NP, Humaidan P, Tournaye H and Tarlatzis B: GnRH-agonist versus GnRH-antagonist IVF cycles: Is the reproductive outcome affected by the incidence of progesterone elevation on the day of HCG triggering? A randomized prospective study. Hum Reprod 27: 1822-1828, 2012.
18. Venetis CA, Kolibianakis EM, Bosdou JK and Tarlatzis BC: Progesterone elevation and probability of pregnancy after IVF: A systematic review and meta-analysis of over 60 000 cycles. Hum Reprod Update 19: 433-457, 2013.
19. Humaidan P, Bungum L, Bungum M and Andersen CY: Ovarian response and pregnancy outcome related to mid-follicular LH levels in women undergoing assisted reproduction with GnRH agonist down-regulation and recombinant FSH stimulation. Hum Reprod 17: 2016-2021, 2002.
20. Sharara FI, Lim J and McClamrock HD: Endometrial pattern on the day of oocyte retrieval is more predictive of implantation success than the pattern or thickness on the day of hCG administration. J Assist Reprod Genet 16: 523-528, 1999.
21. Zhang X, Chen CH, Confino E, Barnes R, Milad M and Kazer RR: Increased endometrial thickness is associated with improved treatment outcome for selected patients undergoing in vitro fertilization-embryo transfer. Fertil Steril 83: 336-340, 2005.
22. Järvelä IY, Sladkevicius P, Kelly S, Ojha K, Campbell S and Nargund G: Evaluation of endometrial receptivity during in-vitro fertilization using three-dimensional power Doppler ultrasound. Ultrasound Obstet Gynecol 26: 765-769, 2005.
23. Kinay T, Tasci Y, Dilbaz S, Cinar O, Demir B and Haberal A: The relationship between endometrial thickness and pregnancy rates in GnRH antagonist down-regulated ICSI cycles. Gynecol Endocrinol 26: 833-837, 2010.
24. Okohue JE, Onuh SO, Ebeigbe P, Shaibu I, Wada I, Ikimalo JI and Okpere EE: The effect of endometrial thickness on in vitro fertilization (IVF)-embryo transfer/intracytoplasmic sperm injection (ICSI) outcome. Afr J Reprod Health 13: 113-121, 2009.
25. Rashidi BH, Sadeghi M, Jafarabadi M and Tehrani Nejad ES: Relationships between pregnancy rates following in vitro fertilization or intracytoplasmic sperm injection and endometrial thickness and pattern. Eur J Obstet Gynecol Reprod Biol 120: 179-184, 2005.
26. Traub ML, Van Arsdale A, Pal L, Jindal S and Santoro N: Endometrial thickness, Caucasian ethnicity, and age predict clinical pregnancy following fresh blastocyst embryo transfer: A retrospective cohort. Reprod Biol Endocrinol 7: 33, 2009.
27. Lintsen AM, Pasker-de Jong PC, de Boer EJ, Burger CW, Jansen CA, Braat DD and van Leeuwen FE: Effects of subfertility cause, smoking and body weight on the success rate of IVF. Hum Reprod 20: 1867-1875, 2005.
28. Raine-Fenning NJ, Campbell BK, Kendall NR, Clewes JS and Johnson IR: Quantifying the changes in endometrial vascularity throughout the normal menstrual cycle with three-dimensional power Doppler angiography. Hum Reprod 19: 330-338, 2004.
29. Jungheim ES, Lanzendorf SE, Odem RR, Moley KH, Chang AS and Ratts VS: Morbid obesity is associated with lower clinical pregnancy rates after in vitro fertilization in women with polycystic ovary syndrome. Fertil Steril 92: 256-261, 2009.
30. Metwally M, Cutting R, Tipton A, Skull J, Ledger WL and Li TC: Effect of increased body mass index on oocyte and embryo quality in IVF patients. Reprod Biomed Online 15: 532-538, 2007.
31. Sneed ML, Uhler ML, Grotjan HE, Rapisarda JJ, Lederer KJ and Beltsos AN: Body mass index: Impact on IVF success appears age-related. Hum Reprod 23: 1835-1839, 2008.